Nazita Yousefieh, Ph.D. - Publications

Affiliations: 
2008 Old Dominion University, Norfolk, VA, United States 
Area:
Immunology, Molecular Biology, Cell Biology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Joseph T, Zalenskaya IA, Yousefieh N, Schriver SD, Cote LC, Chandra N, Doncel GF. Induction of cyclooxygenase (COX)-2 in human vaginal epithelial cells in response to TLR ligands and TNF-α. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 67: 482-90. PMID 22235849 DOI: 10.1111/J.1600-0897.2011.01099.X  0.351
2009 Yousefieh N, Hahto SM, Stephens AL, Ciavarra RP. Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 2: 59-67. PMID 19418243 DOI: 10.1007/S12307-009-0021-Z  0.702
2005 Ciavarra RP, Taylor L, Greene AR, Yousefieh N, Horeth D, van Rooijen N, Steel C, Gregory B, Birkenbach M, Sekellick M. Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon. Virology. 342: 177-89. PMID 16143360 DOI: 10.1016/J.Virol.2005.07.031  0.58
2004 Ciavarra RP, Holterman DA, Brown RR, Mangiotti P, Yousefieh N, Wright GL, Schellhammer PF, Glass WF, Somers KD. Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 13-26. PMID 14676630 DOI: 10.1097/00002371-200401000-00002  0.63
2003 Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright GL, Schellhammer PF, Qian J, Ciavarra RP. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy. International Journal of Cancer. Journal International Du Cancer. 107: 773-80. PMID 14566827 DOI: 10.1002/Ijc.11464  0.619
Show low-probability matches.